MELISSA FACKLER: Open Payments
NPI 1215470257 · MANHASSET, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$420 in 20 payments from 10 companies in 2025. Trend: 2023 $243 · 2024 $727 · 2025 $420
Food & beverage: $401Education: $19
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 3 | $93 |
| Novo Nordisk Inc | 4 | $90 |
| Amgen Inc. | 4 | $61 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| PFIZER INC. | 2 | $36 |
| Tactile Systems Technology Inc | 1 | $31 |
| Baxter Healthcare | 1 | $25 |
| BridgeBio Pharma, Inc. | 1 | $18 |
| HEARTFLOW, INC. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: AMVUTTRA, REPATHA, Ozempic, Wegovy, JARDIANCE, ELIQUIS, Flexitouch Plus, Hillrom - Carnation Ambulatory Monitor.
Industry payments across NY — which companies pay providers there.
